Download PDF
Digestive Disease Interventions 2017; 01(03): 171-183
DOI: 10.1055/s-0037-1606204
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Portal Vein Embolization in the Treatment of Metastatic Colorectal Cancer: Optimal Approach and Current Controversies

Daniel Gans
1   Division of Vascular and Interventional Radiology, Department of Radiology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio
,
Christopher Siegel
2   Division of Hepatobiliary and Transplant Surgery, Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio
,
Indravadan J. Patel
1   Division of Vascular and Interventional Radiology, Department of Radiology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio
,
Sidhartha Tavri
1   Division of Vascular and Interventional Radiology, Department of Radiology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio
,
David C. Madoff
3   Division of Interventional Radiology, Department of Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
Christopher Sutter
1   Division of Vascular and Interventional Radiology, Department of Radiology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

24 May 2017

08 June 2017

Publication Date:
03 August 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Colorectal carcinoma metastatic to the liver is associated with increased morbidity and mortality. Many therapies targeting liver metastasis have been associated with prolonged life and palliation, but few are more effective than surgical resection. Preoperative portal vein embolization (PVE) can facilitate contralateral hepatic lobe hypertrophy, and allow for subsequent surgical resection of metastatic disease in patients whose postoperative residual liver volume is considered marginal or too small to support proper liver function. A thorough preprocedural workup is necessary, including proper multidisciplinary patient selection, imaging, and liver volume measurements. PVE can be performed with multiple approaches and techniques, each with advantages and disadvantages. Both older and newer surgical alternatives exist, including portal vein ligation and the associating liver partition and portal vein ligation in staged hepatectomy strategy. The variability in embolization techniques and surgical alternatives in the treatment of patients with potentially resectable metastatic colorectal cancer in the liver naturally lends itself to controversy. We aim to discuss the workup, pathophysiology, technical details, and outcomes of PVE, as well as surgical alternatives and current controversies.

Keywords

portal vein embolization - colorectal liver metastasis - future liver remnant - portal vein ligation - ALPPS
 

  • References

  • 1 Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64 (02) 104-117
    CrossrefPubMedGoogle Scholar
  • 2 World Health Organization Fact Sheets by Cancer. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=colorectal . Accessed January 2, 2017
    PubMed
  • 3 Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep 2016; 6: 29765
    CrossrefPubMedGoogle Scholar
  • 4 Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier A-M. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244 (02) 254-259
    CrossrefPubMedGoogle Scholar
  • 5 Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230 (03) 309-318 , discussion 318–321
    CrossrefPubMedGoogle Scholar
  • 6 Shirabe K, Shimada M, Gion T. , et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188 (03) 304-309
    CrossrefPubMedGoogle Scholar
  • 7 Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008; 25 (02) 92-103
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000; 4 (02) 178-184
    CrossrefPubMedGoogle Scholar
  • 9 Zorzi D, Mullen JT, Abdalla EK. , et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006; 10 (01) 86-94
    CrossrefPubMedGoogle Scholar
  • 10 Siriwardena AK, Mason JM, Mullamitha S, Hancock HC, Jegatheeswaran S. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol 2014; 11 (08) 446-459
    CrossrefPubMedGoogle Scholar
  • 11 Vauthey JN, Chaoui A, Do KA. , et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127 (05) 512-519
    CrossrefPubMedGoogle Scholar
  • 12 Vauthey J-N, Abdalla EK, Doherty DA. , et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002; 8 (03) 233-240
    CrossrefPubMedGoogle Scholar
  • 13 May BJ, Madoff DC. Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol 2012; 29 (02) 81-89
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal venous interventions: state of the art. Radiology 2016; 278 (02) 333-353
    CrossrefPubMedGoogle Scholar
  • 15 Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey J-N. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137 (06) 675-680 , discussion 680–681
    CrossrefPubMedGoogle Scholar
  • 16 Shindoh J, Truty MJ, Aloia TA. , et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 2013; 216 (02) 201-209
    CrossrefPubMedGoogle Scholar
  • 17 Sheng Q-S, Lang R, He Q, Yang Y-J, Zhao D-F, Chen D-Z. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 2009; 8 (01) 46-49
    PubMedGoogle Scholar
  • 18 Wakiya T, Kudo D, Toyoki Y. , et al. Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis. Ann Surg Oncol 2014; 21 (01) 167-172
    CrossrefPubMedGoogle Scholar
  • 19 Abulkhir A, Limongelli P, Healey AJ. , et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008; 247 (01) 49-57
    CrossrefPubMedGoogle Scholar
  • 20 Denys A, Bize P, Demartines N, Deschamps F, De Baere T. ; Cardiovascular and Interventional Radiological Society of Europe. Quality improvement for portal vein embolization. Cardiovasc Intervent Radiol 2010; 33 (03) 452-456
    CrossrefPubMedGoogle Scholar
  • 21 Madoff DC, Abdalla EK, Vauthey J-N. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005; 16 (06) 779-790
    CrossrefPubMedGoogle Scholar
  • 22 Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 2007; 31 (02) 367-374
    CrossrefPubMedGoogle Scholar
  • 23 Madoff DC, Hicks ME, Vauthey J-N. , et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics 2002; 22 (05) 1063-1076
    CrossrefPubMedGoogle Scholar
  • 24 Patel IJ, Davidson JC, Nikolic B. , et al; Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement; Standards of Practice Committee of the Society of Interventional Radiology. Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol 2013; 24 (05) 641-645
    CrossrefPubMedGoogle Scholar
  • 25 Covey AM, Brody LA, Getrajdman GI, Sofocleous CT, Brown KT. Incidence, patterns, and clinical relevance of variant portal vein anatomy. AJR Am J Roentgenol 2004; 183 (04) 1055-1064
    CrossrefPubMedGoogle Scholar
  • 26 Koç Z, Oğuzkurt L, Ulusan S. Portal vein variations: clinical implications and frequencies in routine abdominal multidetector CT. Diagn Interv Radiol 2007; 13 (02) 75-80
    PubMedGoogle Scholar
  • 27 Sureka B, Patidar Y, Bansal K, Rajesh S, Agrawal N, Arora A. Portal vein variations in 1000 patients: surgical and radiological importance. Br J Radiol 2015; 88 (1055): 20150326
    CrossrefPubMedGoogle Scholar
  • 28 Orcutt ST, Kobayashi K, Sultenfuss M. , et al. Portal vein embolization as an oncosurgical strategy prior to major hepatic resection: anatomic, surgical, and technical considerations. Front Surg 2016; 3: 14
    PubMedGoogle Scholar
  • 29 May BJ, Madoff DC. Controversies of preoperative portal vein embolization. Hepat Oncol 2016; 3 (02) 155-166
    CrossrefPubMedGoogle Scholar
  • 30 Perarnau J-M, Daradkeh S, Johann M, Deneuville M, Weinling P, Coniel C. Transjugular preoperative portal embolization (TJPE) a pilot study. Hepatogastroenterology 2003; 50 (51) 610-613
    PubMedGoogle Scholar
  • 31 Sarwar A, Brook OR, Weinstein JL, Khwaja K, Ahmed M. Trans-splenic portal vein embolization: a technique to avoid damage to the future liver remnant. Cardiovasc Intervent Radiol 2016; 39 (10) 1514-1518
    CrossrefPubMedGoogle Scholar
  • 32 Saad WEA, Madoff DC. Percutaneous portal vein access and transhepatic tract hemostasis. Semin Intervent Radiol 2012; 29 (02) 71-80
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Adam R, Delvart V, Pascal G. , et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240 (04) 644-657 , discussion 657–658
    PubMedGoogle Scholar
  • 34 Elias D, De Baere T, Roche A, , Mducreux, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86 (06) 784-788
    CrossrefPubMedGoogle Scholar
  • 35 Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber J-C, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240 (06) 1037-1049 , discussion 1049–1051
    CrossrefPubMedGoogle Scholar
  • 36 Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol 2014; 5 (05) 374-387
    PubMedGoogle Scholar
  • 37 Elias D, Ouellet J-F, De Baère T, Lasser P, Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002; 131 (03) 294-299
    CrossrefPubMedGoogle Scholar
  • 38 Madoff DC, Abdalla EK, Gupta S. , et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 2005; 16 (2, Pt 1): 215-225
    CrossrefPubMedGoogle Scholar
  • 39 van Lienden KP, van den Esschert JW, de Graaf W. , et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013; 36 (01) 25-34
    CrossrefPubMedGoogle Scholar
  • 40 Guiu B, Bize P, Gunthern D, Demartines N, Halkic N, Denys A. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol 2013; 36 (05) 1306-1312
    CrossrefPubMedGoogle Scholar
  • 41 Jaberi A, Toor SS, Rajan DK. , et al. Comparison of clinical outcomes following glue versus polyvinyl alcohol portal vein embolization for hypertrophy of the future liver remnant prior to right hepatectomy. J Vasc Interv Radiol 2016; 27 (12) 1897-1905.e1
    CrossrefPubMedGoogle Scholar
  • 42 Tsoumakidou G, Theocharis S, Ptohis N. , et al. Liver hypertrophy after percutaneous portal vein embolization: comparison of N-butyl-2-cyanocrylate versus sodium acrylate-vinyl alcohol copolymer particles in a swine model. Cardiovasc Intervent Radiol 2011; 34 (05) 1042-1049
    CrossrefPubMedGoogle Scholar
  • 43 de Baere T, Denys A, Paradis V. Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol 2009; 19 (06) 1435-1442
    CrossrefPubMedGoogle Scholar
  • 44 Capussotti L, Muratore A, Baracchi F. , et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 2008; 143 (10) 978-982 , discussion 982
    CrossrefPubMedGoogle Scholar
  • 45 Vennarecci G, Laurenzi A, Santoro R, Colasanti M, Lepiane P, Ettorre GM. The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion. World J Surg 2014; 38 (06) 1498-1503
    CrossrefPubMedGoogle Scholar
  • 46 Broering DC, Hillert C, Krupski G. , et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002; 6 (06) 905-913 , discussion 913
    CrossrefPubMedGoogle Scholar
  • 47 Aussilhou B, Lesurtel M, Sauvanet A. , et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12 (02) 297-303
    CrossrefPubMedGoogle Scholar
  • 48 Denys AL, Abehsera M, Sauvanet A, Sibert A, Belghiti J, Menu Y. Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization. AJR Am J Roentgenol 1999; 173 (03) 633-635
    CrossrefPubMedGoogle Scholar
  • 49 Pandanaboyana S, Bell R, Hidalgo E. , et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery 2015; 157 (04) 690-698
    CrossrefPubMedGoogle Scholar
  • 50 Shindoh J, Vauthey JN, Zimmitti G. , et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 2013; 217 (01) 126-133 , discussion 133–134
    CrossrefPubMedGoogle Scholar
  • 51 Aloia TA, Vauthey J-N. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?. Ann Surg 2012; 256 (03) e9 , author reply e16–e19
    CrossrefPubMedGoogle Scholar
  • 52 Oldhafer KJ, Donati M, Jenner RM, Stang A, Stavrou GA. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J Surg 2014; 38 (06) 1504-1509
    CrossrefPubMedGoogle Scholar
  • 53 Garlipp B, de Baere T, Damm R. , et al. Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization. Hepatology 2014; 59 (05) 1864-1873
    CrossrefPubMedGoogle Scholar
  • 54 Teo J-Y, Allen Jr JC, Ng DC. , et al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. HPB (Oxford) 2016; 18 (01) 7-12
    CrossrefPubMedGoogle Scholar
  • 55 Kishi Y, Madoff DC, Abdalla EK. , et al. Is embolization of segment 4 portal veins before extended right hepatectomy justified?. Surgery 2008; 144 (05) 744-751
    CrossrefPubMedGoogle Scholar
  • 56 Nagino M, Nimura Y, Kamiya J. , et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995; 117 (06) 677-681
    CrossrefPubMedGoogle Scholar
  • 57 Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey J-N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94 (11) 1386-1394
    CrossrefPubMedGoogle Scholar
  • 58 Mise Y, Aloia TA, Conrad C, Huang SY, Wallace MJ, Vauthey J-N. Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg 2015; 19 (01) 133-141 , discussion 141
    CrossrefPubMedGoogle Scholar